EP Biocomposites profit jumps 41.5% in FY26
The company reported a net profit of ₹1.46 crore on revenue of ₹13.64 crore. Debt is down and the equity base is larger.
What's new
- Net profit rose 41.5% to ₹1.46 crore for FY26.
- Revenue grew 13.6% to reach ₹13.64 crore.
- The balance sheet shows lower debt and a larger equity base.
Why this matters
Profit growth is outpacing revenue gains. This shows the company is keeping more of every rupee earned. A cleaner balance sheet provides a stable foundation for future operations.
What we're watching
- Whether the company maintains this profit growth rate.
- Details on the specific debt reduction measures taken.
- Management commentary on the revenue trajectory.
The full read
EP Biocomposites delivered a solid performance in FY26. Net profit rose 41.5% to ₹1.46 crore, while revenue grew 13.6% to ₹13.64 crore.
Profit growth is significantly higher than revenue growth, indicating the company is keeping more of its earnings while simultaneously cleaning up its balance sheet through debt reduction and a larger equity base.
It is a routine annual results filing.
The next test is whether the company can maintain this pace as it scales.
Questions answered
- How much did EP Biocomposites earn in FY26?
- The company reported a net profit of ₹1.46 crore. This is a 41.5% increase over the previous year.
- What was the revenue performance for the year?
- Revenue for FY26 reached ₹13.64 crore. This represents a 13.6% growth.
- What is the state of the company's balance sheet?
- The company has reduced its debt. It also reports a larger equity base.
- Is this a major event for investors?
- No. Financial results are a standard filing under SEBI regulations.